{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T18:19:57Z","timestamp":1784744397985,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010656","name":"School of Medicine, Tokai University","doi-asserted-by":"publisher","award":["IRB 20R-117"],"award-info":[{"award-number":["IRB 20R-117"]}],"id":[{"id":"10.13039\/501100010656","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.modpat.2025.100950","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:22:50Z","timestamp":1765239770000},"page":"100950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Redefining the Spectrum of Epstein-Barr Virus\u2013Positive (EBV+) Diffuse Large B-cell Lymphoma and EBV+ Classic Hodgkin Lymphoma"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6130-3879","authenticated-orcid":false,"given":"Shunsuke","family":"Nagase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara Yukie","family":"Kikuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Carreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Tanigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Orita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Ikoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Masugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.modpat.2025.100950_bib1","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1349-7006.2000.tb00909.x","article-title":"The characteristics of Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma: comparison between EBV(+) and EBV(-) cases in Japanese population","volume":"91","author":"Kuze","year":"2000","journal-title":"Jpn J Cancer Res"},{"issue":"1","key":"10.1016\/j.modpat.2025.100950_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00000478-200301000-00003","article-title":"Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients","volume":"27","author":"Oyama","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2025.100950_bib3","series-title":"WHO Classification of Tumours. Haematolymphoid Tumours","year":"2024"},{"issue":"11","key":"10.1016\/j.modpat.2025.100950_bib4","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.modpat.2025.100950_bib5","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood-2007-01-067769","article-title":"The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma","volume":"110","author":"Park","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.modpat.2025.100950_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/10428194.2015.1040014","article-title":"In Europe expression of EBNA2 is associated with poor survival in EBV-positive diffuse large B-cell lymphoma of the elderly","volume":"57","author":"Stuhlmann-Laeisz","year":"2016","journal-title":"Leuk Lymphoma"},{"issue":"16","key":"10.1016\/j.modpat.2025.100950_bib7","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1182\/bloodadvances.2021004515","article-title":"Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified","volume":"5","author":"Bourbon","year":"2021","journal-title":"Blood Adv"},{"issue":"19","key":"10.1016\/j.modpat.2025.100950_bib8","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1002\/cam4.4198","article-title":"EBV-positive B-cell lymphomas and lymphoproliferative disorders: review from the perspective of immune escape and immunodeficiency","volume":"10","author":"Satou","year":"2021","journal-title":"Cancer Med"},{"issue":"11","key":"10.1016\/j.modpat.2025.100950_bib9","first-page":"3615","article-title":"Epstein-Barr virus and immune status imprint the immunogenomics of non-Hodgkin lymphomas occurring in immune-suppressed environments","volume":"109","author":"Baron","year":"2024","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.modpat.2025.100950_bib10","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/ajh.27430","article-title":"EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2024 update on the diagnosis, risk-stratification, and management","volume":"99","author":"Malpica","year":"2024","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100950_bib11","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/2159-8290.CD-19-0680","article-title":"Single-cell transcriptome analysis reveals disease-defining T-cell subsets in the tumor microenvironment of classic Hodgkin lymphoma","volume":"10","author":"Aoki","year":"2020","journal-title":"Cancer Discov"},{"issue":"17","key":"10.1016\/j.modpat.2025.100950_bib12","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","article-title":"Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.modpat.2025.100950_bib13","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1200\/JCO.2016.66.4482","article-title":"PD-L1 and PD-L2 genetic alterations define classical Hodgkin lymphoma and predict outcome","volume":"34","author":"Roemer","year":"2016","journal-title":"J Clin Oncol"},{"issue":"7996","key":"10.1016\/j.modpat.2025.100950_bib14","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41586-023-06903-x","article-title":"Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling","volume":"625","author":"Alig","year":"2024","journal-title":"Nature"},{"issue":"35","key":"10.1016\/j.modpat.2025.100950_bib15","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1200\/JCO.23.01867","article-title":"Circulating tumor DNA sequencing for biologic classification and individualized risk stratification in patients with Hodgkin lymphoma","volume":"42","author":"Heger","year":"2024","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100950_bib16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/(SICI)1097-0142(19960101)77:1<186::AID-CNCR30>3.0.CO;2-#","article-title":"Epstein-Barr virus in Hodgkin\u2019s disease patients in Japan","volume":"77","author":"Tomita","year":"1996","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.modpat.2025.100950_bib17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood.2019000568","article-title":"An etiological role for the Epstein-Barr virus in the pathogenesis of classical Hodgkin lymphoma","volume":"134","author":"Murray","year":"2019","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.modpat.2025.100950_bib18","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/01.MP.0000071843.09960.BF","article-title":"Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin\u2019s lymphoma: a single-institution study","volume":"16","author":"Krugmann","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2025.100950_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/1471-2407-14-335","article-title":"Indoleamine 2,3-dioxygenase (IDO) is frequently expressed in stromal cells of Hodgkin lymphoma and is associated with adverse clinical features: a retrospective cohort study","volume":"14","author":"Choe","year":"2014","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.modpat.2025.100950_bib20","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1002\/ajh.27470","article-title":"Hodgkin lymphoma: 2025 update on diagnosis, risk-stratification, and management","volume":"99","author":"Ansell","year":"2024","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100950_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/bjh.15614","article-title":"Diagnosis of Hodgkin lymphoma in the modern era","volume":"184","author":"Wang","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.modpat.2025.100950_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2024.105697","article-title":"Epstein-Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: diagnostic overlaps and defining features","volume":"156","author":"Volaric","year":"2025","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.modpat.2025.100950_bib23","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2015-02-630632","article-title":"EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment","volume":"126","author":"Nicolae","year":"2015","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.modpat.2025.100950_bib24","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1182\/blood-2008-06-164806","article-title":"Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients","volume":"113","author":"Asano","year":"2009","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.modpat.2025.100950_bib25","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.humpath.2008.10.007","article-title":"Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype","volume":"40","author":"Gibson","year":"2009","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100950_bib26","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.humpath.2009.07.024","article-title":"Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations","volume":"41","author":"Hoeller","year":"2010","journal-title":"Hum Pathol"},{"issue":"18","key":"10.1016\/j.modpat.2025.100950_bib27","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1182\/blood-2010-12-323238","article-title":"Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma","volume":"117","author":"Dojcinov","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.modpat.2025.100950_bib28","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41408-021-00493-5","article-title":"Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing","volume":"11","author":"Gebauer","year":"2021","journal-title":"Blood Cancer J"},{"issue":"8","key":"10.1016\/j.modpat.2025.100950_bib29","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jmoldx.2025.05.002","article-title":"Comparison of the mutational profile between BCL2- and BCL6-rearrangement positive follicular lymphoma","volume":"27","author":"Ikoma","year":"2025","journal-title":"J Mol Diagn"},{"issue":"1","key":"10.1016\/j.modpat.2025.100950_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.modpat.2025.100950_bib31","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/PAS.0000000000001899","article-title":"9p24.1 Genetic alteration and PD-L1 expression are characteristic of de novo and methotrexate-associated Epstein-Barr virus-positive Hodgkin lymphoma, but not methotrexate-associated Hodgkin-like lesions","volume":"46","author":"Shiraiwa","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100950_bib32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1525-1578(10)60455-2","article-title":"Analysis of microarray data using Z score transformation","volume":"5","author":"Cheadle","year":"2003","journal-title":"J Mol Diagn"},{"issue":"43","key":"10.1016\/j.modpat.2025.100950_bib33","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.modpat.2025.100950_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"7607","key":"10.1016\/j.modpat.2025.100950_bib35","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature18294","article-title":"Aberrant PD-L1 expression through 3'-UTR disruption in multiple cancers","volume":"534","author":"Kataoka","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.modpat.2025.100950_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101573","article-title":"Role of indoleamine 2,3-dioxygenase 1 (IDO1) and kynurenine pathway in the regulation of the aging process","volume":"75","author":"Salminen","year":"2022","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.modpat.2025.100950_bib37","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2244330","article-title":"L-Kynurenine participates in cancer immune evasion by downregulating hypoxic signaling in T lymphocytes","volume":"12","author":"Schlichtner","year":"2023","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.modpat.2025.100950_bib38","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00277-010-1093-z","article-title":"Indoleamine 2,3-dioxygenase in tumor tissue indicates prognosis in patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"90","author":"Ninomiya","year":"2011","journal-title":"Ann Hematol"},{"issue":"20","key":"10.1016\/j.modpat.2025.100950_bib39","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1111\/febs.16086","article-title":"Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme","volume":"289","author":"Pallotta","year":"2022","journal-title":"FEBS J"},{"issue":"6","key":"10.1016\/j.modpat.2025.100950_bib40","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/gcc.22249","article-title":"Integrated copy number and gene expression profiling analysis of Epstein-Barr virus-positive diffuse large B-cell lymphoma","volume":"54","author":"Yoon","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"10.1016\/j.modpat.2025.100950_bib41","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-021-00566-3","article-title":"Interferon-\u03b3: teammate or opponent in the tumour microenvironment?","volume":"22","author":"Gocher","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100950_bib42","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1158\/2643-3230.BCD-22-0128","article-title":"Molecular evolution of classic Hodgkin lymphoma revealed through whole-genome sequencing of Hodgkin and Reed Sternberg cells","volume":"4","author":"Maura","year":"2023","journal-title":"Blood Cancer Discov"},{"issue":"3","key":"10.1016\/j.modpat.2025.100950_bib43","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41375-022-01804-w","article-title":"Molecular profiling of EBV associated diffuse large B-cell lymphoma","volume":"37","author":"Frontzek","year":"2023","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.modpat.2025.100950_bib44","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/s41467-018-04013-1","article-title":"The molecular basis of JAK\/STAT inhibition by SOCS1","volume":"9","author":"Liau","year":"2018","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.modpat.2025.100950_bib45","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0092-8674(00)80047-1","article-title":"SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine","volume":"98","author":"Alexander","year":"1999","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.modpat.2025.100950_bib46","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMra2314005","article-title":"Hemophagocytic lymphohistiocytosis","volume":"392","author":"Henter","year":"2025","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.modpat.2025.100950_bib47","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/s41375-019-0380-5","article-title":"Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas","volume":"33","author":"Kataoka","year":"2019","journal-title":"Leukemia"},{"issue":"20","key":"10.1016\/j.modpat.2025.100950_bib48","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1182\/bloodadvances.2023010330","article-title":"Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b\/2 study","volume":"7","author":"Haverkos","year":"2023","journal-title":"Blood Adv"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395225002480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395225002480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T07:47:24Z","timestamp":1781336844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395225002480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0893395225002480"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100950","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redefining the Spectrum of Epstein-Barr Virus\u2013Positive (EBV+) Diffuse Large B-cell Lymphoma and EBV+ Classic Hodgkin Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}],"article-number":"100950"}}